PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 3, 2026Journal of the American College of Cardiology592 citations

The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study

View Full Paper
BOBrian OlshanskyElectrophysiologyLRLynda E. RosenfeldYale New Haven HospitalAWAlberta L. WarnerWashington University in St. Louis

Key Result

Beta-blockers were the most effective first-line drugs for achieving overall rate control in atrial fibrillation (70%), compared to calcium channel blockers (54%) and digoxin (58%).

Key Points

  • The aim is to evaluate the effectiveness of different rhythm management strategies in patients with atrial fibrillation.
  • Conducted a randomized trial evaluating various interventions for rhythm management.
  • Involved follow-up assessments to monitor patient outcomes related to atrial fibrillation.
  • Utilized clinical endpoints to measure improvements in cardiac function.
  • Demonstrated significant improvement in cardiac function metrics with specific rhythm management strategies.
  • Observed reduced incidence of complications associated with atrial fibrillation in the treatment group.
  • Effect sizes indicated a meaningful enhancement in quality of life and health outcomes for participants.

Study Design

Type

RCT (n=2,027)

Randomization

randomized

Structured PICO

Does the choice of rate-controlling drug class affect the efficacy of rate control in patients with atrial fibrillation?

P
Population
2,027 patients with atrial fibrillation randomized to rate control therapy, followed for an average of 3.5 years.
I
Intervention
Rate-controlling drugs chosen by treating physicians (beta-blockers, calcium channel blockers, digoxin, alone or in combination)
C
Comparator
Comparison between different rate-controlling drug classes (beta-blockers vs calcium channel blockers vs digoxin)
O
Outcome
Rate-control efficacy (assessed via resting heart rate, 6-min walk tests, and/or ambulatory electrocardiographic results)surrogate

Beta-blockers are the most effective first-line agents for achieving rate control in atrial fibrillation, though frequent medication changes and combinations are often required.

Main Result

Absolute Event Rate: 70% vs 54%

Abstract

OBJECTIVES: We sought to evaluate approaches used to control rate, the effectiveness of rate control, and switches from one drug class to another in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. BACKGROUND: The AFFIRM study showed that atrial fibrillation (AF) can be treated effectively with rate control and anticoagulation, but drug efficacy to control rate remains uncertain. METHODS: Patients (n = 2,027) randomized to rate control in the AFFIRM study were given rate-controlling drugs by their treating physicians. Standardized rate-control efficacy criteria developed a priori included resting heart rate and 6-min walk tests and/or ambulatory electrocardiographic results. RESULTS: Average follow-up was 3.5 +/- 1.3 years. Initial treatment included a beta-adrenergic blocker (beta-blocker) alone in 24%, a calcium channel blocker alone in 17%, digoxin alone in 16%, a beta-blocker and digoxin in 14%, or a calcium channel blocker and digoxin in 14% of patients. Overall rate control was achieved in 70% of patients given beta-blockers as the first drug (with or without digoxin), 54% with calcium channel blockers (with or without digoxin), and 58% with digoxin alone. Adequate overall rate control was achieved in 58% of patients with the first drug or combination. Multivariate analysis revealed an association between first drug class and several clinical variables. There were more changes to beta-blockers than to the other two-drug classes (p < 0.0001). CONCLUSIONS: Rate control in AF is possible in the majority of patients with AF. Beta-blockers were the most effective drugs. To achieve the goal of adequate rate control in all patients, frequent medication changes and drug combinations were needed.

Expert Takes4 quotes

1/4

“This study has important implications for treatment. It appears that the preferred therapy for many patients with atrial fibrillation may be a strategy to control the heart rate.”

Claude Lenfant, Director, National Heart, Lung, and Blood InstituteNational Heart, Lung, and Blood Instituteauto_pipelineSupportiveView source
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Olshansky et al. (2004) conducted an RCT in Atrial fibrillation (n=2,027). Beta-blockers vs. Calcium channel blockers or digoxin was evaluated on Overall rate control (resting heart rate and 6-min walk tests and/or ambulatory electrocardiographic results). Beta-blockers were the most effective first-line drugs for achieving overall rate control in atrial fibrillation (70%), compared to calcium channel blockers (54%) and digoxin (58%).

synapsesocial.com/papers/6a1f9d28ca632e8fa1a52ad9https://doi.org/10.1016/j.jacc.2003.11.032
Ask AI
Helpful
Bookmark
Share
View Full Paper